At left, Gary Stevenson
The Pitt Hyde-founded life-sciences investor will soon be on the prowl again, in a target-rich marketplace of down-valued companies
You may not be getting all you can out of your browsing experience
and may be open to security risks!
Consider upgrading to the latest version of your browser or choose on below: